Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
10,000+ US Securities
Unlisted Companies not available on US Stock Exchanges
Professionally managed portfolios, designed by Vested’s research team
Get exposure to 50+ countries via global funds managed by the world’s top fund managers
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). more
| Time Frame | XBI | S&P500 |
|---|---|---|
| 1-Week Return | 3.29% | 1.51% |
| 1-Month Return | 3.11% | 8.24% |
| 3-Month Return | 6.82% | 5.38% |
| 6-Month Return | 22.36% | 7.35% |
| 1-Year Return | 72.62% | 29.5% |
| 3-Year Return | 58.48% | 77.37% |
| 5-Year Return | 9.44% | 75.04% |
| 10-Year Return | 157.97% | 256.12% |
| Time Frame | XBI | S&P500 |
|---|---|---|
| 1-Week Return | 440.80% | 118.47% |
| 1-Month Return | 45.15% | 162.05% |
| 3-Month Return | 30.68% | 23.68% |
| 6-Month Return | 50.56% | 15.47% |
| 1-Year Return | 72.62% | 29.50% |
| 3-Year Return | 16.59% | 21.05% |
| 5-Year Return | 1.82% | 11.85% |
| 10-Year Return | 9.94% | 13.54% |
| Stock name | Ticker | Weight |
|---|---|---|
Apellis Pharmaceuticals Inc | APLS | 1.83% |
Travere Therapeutics Inc | TVTX | 1.7% |
Revolution Medicines Inc | RVMD | 1.66% |
Arrowhead Pharmaceuticals Inc | ARWR | 1.47% |
TG Therapeutics Inc | TGTX | 1.42% |
Celcuity LLC | CELC | 1.4% |
Alkermes Plc | ALKS | 1.38% |
Twist Bioscience Corp | TWST | 1.34% |
Madrigal Pharmaceuticals Inc | MDGL | 1.34% |
Beam Therapeutics Inc | BEAM | 1.29% |
| Sector | Weight |
|---|---|
|
Health care | 99.78% |
|
Financials | 0.22% |
SPDR® S&P Biotech ETF (XBI) share price today is $134.71.
Yes, Indians can buy shares of SPDR® S&P Biotech ETF (XBI) on Vested. To buy XBI from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of SPDR® S&P Biotech ETF (XBI) on Vested. You can start investing in SPDR® S&P Biotech ETF (XBI) with a minimum investment of $1.
The 52-week high price of SPDR® S&P Biotech ETF (XBI) is $139.19. The 52-week low price of SPDR® S&P Biotech ETF (XBI) is $75.43.
The stock symbol (or ticker) of SPDR® S&P Biotech ETF is XBI.
Yes, you can setup SIP in SPDR® S&P Biotech ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of XBI on the Vested app.
The expense ratio of SPDR® S&P Biotech ETF (XBI) is 0.35%.
Link copied